Results 351 to 360 of about 5,138,464 (395)

Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States

Addiction, 2017
P. Moyo, L. Simoni-Wastila, B. Griffin, E. Onukwugha, D. Harrington, G. Alexander, F. Palumbo   +6 more
semanticscholar   +1 more source

Prescription Drugs

JAMA, 2005
  +4 more sources

Advertising Prescription Drugs

Science, 1983
openaire   +2 more sources

Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health

Annals of Internal Medicine, 2017
B. Han, W. Compton, C. Blanco, E. Crane, Jinhee Lee, Christopher M. Jones   +5 more
semanticscholar   +1 more source

Prescription and non-prescription drugs

Abstract Descriptions of prescription-only medicine (POM), pharmacy (P), and general sales list (GSL) provisions are included, with reference to reclassification and life cycle management.
Phil Ambery, Adrian Kilcoyne, Daniel O’Connor   +2 more
openaire   +1 more source

Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity.

Drug and Alcohol Dependence, 2017
Richard P. Brown, Moira R. Riley, Lydia Ulrich, E. Kraly, P. Jenkins, N. Krupa, A. Gadomski   +6 more
semanticscholar   +1 more source

Regarding Drug Prescriptions and Prescription Drugs

New England Journal of Medicine, 1962
openaire   +1 more source

Prescription Drugs

2022
openaire   +1 more source

Do more robust prescription drug monitoring programs reduce prescription opioid overdose?

Addiction, 2016
Bryce Pardo
semanticscholar   +1 more source

Estrogen replacement therapy in patients with endometrial cancer: a survey of prescription intention of Belgian gynecologists

Ca-A Cancer Journal for Clinicians, 1999
Serge Rozenberg
exaly